Abstract
5-HT2 receptors mediate a large array of physiological and behavioral functions in humans via three distinct subtypes: 5-HT2A, 5-HT2B and 5-HT2C. While selective 5-HT2A antagonists have been known for some time, knowledge of the precise role played by the 5-HT2B receptor was hampered by the existence of solely 5- HT2B / 5-HT2C mixed antagonists. However, selective 5-HT2B antagonists began recently to emerge in the literature. Indeed, four structural classes belonging to the piperazine, indole, naphthylpyrimidine and tetrahydro-β-carboline scaffolds were reported. In this paper, we will briefly review the structural and pharmacological features of selective 5-HT2B antagonists, including patent literature of the last five years.
Keywords: receptor, antagonist, serotonin, review
Mini-Reviews in Medicinal Chemistry
Title: The Emergence of Selective 5-HT2B Antagonists Structures, Activities and Potential Therapeutic Applications [General Reviews]
Volume: 4 Issue: 3
Author(s): G. Poissonnet, J. G. Parmentier, J. A. Boutin and S. Goldstein
Affiliation:
Keywords: receptor, antagonist, serotonin, review
Abstract: 5-HT2 receptors mediate a large array of physiological and behavioral functions in humans via three distinct subtypes: 5-HT2A, 5-HT2B and 5-HT2C. While selective 5-HT2A antagonists have been known for some time, knowledge of the precise role played by the 5-HT2B receptor was hampered by the existence of solely 5- HT2B / 5-HT2C mixed antagonists. However, selective 5-HT2B antagonists began recently to emerge in the literature. Indeed, four structural classes belonging to the piperazine, indole, naphthylpyrimidine and tetrahydro-β-carboline scaffolds were reported. In this paper, we will briefly review the structural and pharmacological features of selective 5-HT2B antagonists, including patent literature of the last five years.
Export Options
About this article
Cite this article as:
Poissonnet G., Parmentier G. J., Boutin A. J. and Goldstein S., The Emergence of Selective 5-HT2B Antagonists Structures, Activities and Potential Therapeutic Applications [General Reviews], Mini-Reviews in Medicinal Chemistry 2004; 4 (3) . https://dx.doi.org/10.2174/1389557043487312
DOI https://dx.doi.org/10.2174/1389557043487312 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Magnetic Resonance Imaging of Short T2 Relaxation Components in Tissue Using Ultrashort Echo Time (UTE) Pulse Sequences
Current Medical Imaging A Hyperlipidemic Diet Induces Structural Changes in Cerebral Blood Vessels
Current Neurovascular Research Antibiotics Associated Disorders and Post-biotics Induced Rescue in Gut Health
Current Pharmaceutical Design Toll-Like Receptors: Sensor Molecules for Detecting Damage to the Nervous System
Current Protein & Peptide Science Assays to Predict Drug Permeation Across the Blood-Brain Barrier, and Distribution to Brain
Current Drug Metabolism Synthesis, Structure and Antibacterial Evaluation of Some N-substituted 3-amino-5-hydroxy-4-phenyl-1H-pyrazole-1-carboxamides
Medicinal Chemistry Recent Advances on Neural Tube Defects with Special Reference to Valproic Acid
Endocrine, Metabolic & Immune Disorders - Drug Targets Emergence of Multi-Drug Resistance Gram-Positive Bacteria and New Active Antibiotics
Current Medicinal Chemistry - Anti-Infective Agents Advances in TB Vaccinology
Current Respiratory Medicine Reviews Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy Can Mycobacterial Genomics Generate Novel Targets as Speed-Breakers Against the Race for Drug Resistance
Current Pharmaceutical Design Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design CT and MR Imaging of the Encephalopathic Child
Current Medical Imaging A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Current Drug Targets Inflammatory Cytokines in Acute Ischemic Stroke
Current Pharmaceutical Design Pathogenesis of Central Nervous System Tuberculosis
Current Molecular Medicine Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design Improving the Stability of Aptamers by Chemical Modification
Current Medicinal Chemistry Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Current Stem Cell Research & Therapy